Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.Acura’s new drug application for pain drug accepted for filing by FDA
The user fee goal date under the Prescription Drug User Fee Act is June 30, 2009. The FDA may grant a new drug application a priority review classification
The user fee goal date under the Prescription Drug User Fee Act is June 30, 2009. The FDA may grant a new drug application a priority review classification
Bausch & Lomb, the global eye health company, has entered into a licensing agreement with Santen Pharmaceutical, a developer of ophthalmic and anti-rheumatic pharmaceuticals, for the development of
Medtronic, a medical technology company, has signed a definitive agreement to acquire CoreValve, a developer of a transcatheter, transfemoral aortic valve replacement product. This non-surgical alternative offers the
Throug this collaboration, Complete Genomics will use its DNA sequencing technology to sequence five genomes from samples provided by the Broad Institute. The first genome sequenced will be
The Phase II, double blind, vehicle-controlled cross-over study is designed to determine the anti-pruritic efficacy, safety and local dermal toleration of SRD174 cream in patients with atopic dermatitis.
As CFO at JDSU Corp, he designed and implemented restructuring plans for the company’s Asia Pacific organization. Ede has served as a director on Mindray’s board since the
Dr Jay is the managing partner of the Medical Solutions Fund of Siemens Venture Capital, the venture organization for Siemens. Prior to joining Siemens Venture Capital, Dr Jay
As president of Integra NeuroSciences, Mr Thatcher will be responsible for the management of Integra’s foundational division and provide the strategic direction and leadership required to expand the
For the last three years, Mr Sweet served as vice president of marketing and sales for Celerus Diagnostics where he created a sales, marketing and customer care team
Under the terms of the agreements, Pfizer has acquired rights to 39 generic solid oral dose products in the US and 20 in Europe, plus an additional 11